Platform Process for an Autonomous Production of Virus-like Particles
ACS Omega · 04.02.2025 · 10 (4) · 3917-3929
DOI: 10.1021/acsomega.4c09694 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 21.01.2025. Verfasst von Simon Baukmann und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Separation and Process Technology, Clausthal University of Technology, 38678 Clausthal-Zellerfeld, Germany. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Virus-like particles (VLPs) are a promising platform as carriers for vaccination and general treatments against many pathogens. While there are long development timelines and challenges in the production of clinical-grade VLPs, this study introduces a platform process for the production and purification of those particles, aided by process analytical technology (PAT). Fed-batch cultivation and consecutive purification, including novel membrane technology and anion-exchange chromatography, showed robust process performance with design and control spaces defined in previous studies. A novel, stable HEK293F cell line generated using the highly efficient Sleeping Beauty transposon vector technology showed a 3.6-fold increase in productivity compared to a reference cell line established using PiggyBac vector components. The in situ microscope from SOPAT GmbH successfully predicted the viable cell density of a mammalian cell culture, which had been demonstrated for the first time with this type of ISM. Furthermore, Raman, FTIR, and DAD spectroscopies were able to predict the main metabolites and impurities when implemented in the upstream process. FTIR spectra also depicted changes in the buffer composition, therefore enabling robust process control for the prediction of the buffer exchange rate during diafiltration. The applied PAT strategy can deliver real-time data, which is crucial when predictive control is realized with a digital twin. Combined with a robust platform process, the stated control strategy can pave the way toward the autonomous production of VLPs.
Autor:innen und Institutionen
- Institute for Separation and Process Technology, Clausthal University of Technology, 38678 Clausthal-Zellerfeld, Germany.
- Research Group Medical Biotechnology & Bioengineering, Faculty of Applied Natural Sciences, TH Köln - University of Applied Sciences, 51368 Leverkusen, Germany.
ORCID-Profile: Alina Hengelbrock, Axel Schmidt, Jochen Strube
Zitieren
APA
Baukmann, S., Hengelbrock, A., Katsoutas, K., Stitz, J., Schmidt, A., & Strube, J. (2025). Platform Process for an Autonomous Production of Virus-like Particles. ACS Omega, 10(4), 3917-3929. https://doi.org/10.1021/acsomega.4c09694
Vancouver
Baukmann S, Hengelbrock A, Katsoutas K, Stitz J, Schmidt A, Strube J. Platform Process for an Autonomous Production of Virus-like Particles. ACS Omega. 2025;10(4):3917-3929. doi:10.1021/acsomega.4c09694
BibTeX
@article{Baukmann2025,
author = {Baukmann, Simon and Hengelbrock, Alina and Katsoutas, Kristina and Stitz, Jörn and Schmidt, Axel and Strube, Jochen},
title = {Platform Process for an Autonomous Production of Virus-like Particles},
journal = {ACS Omega},
year = {2025},
volume = {10},
number = {4},
pages = {3917--3929},
doi = {10.1021/acsomega.4c09694}
}
EUVIMED